Skip to main content

Latest stock market podcasts

From the helm: CSL's David Lamont on the biotech giant's bright future

Bell Direct
February 20, 2020

In the latest instalment of Bell Direct’s From the helm series, Jess has a chat with CSL’s CFO David Lamont. 

David gives the inside scoop on CSL, the market leader in the blood plasma and vaccine market. Additionally, he explains CSL’s own products, programmes and partnerships, and the steps taken by the medical giant to tackle coronavirus.

Plus, he sheds some light on the unique situation the broader pharmaceuticals industry finds itself in when it comes to new competition, as well as CSL’s future proofing strategy.

Morning Bell 28 March

Bell Direct
March 28, 2024

Morning Bell 27 March

Bell Direct
March 27, 2024

Morning Bell 26 March

Bell Direct
March 26, 2024

Morning Bell 25 March

Bell Direct
March 25, 2024

Weekly Wrap 22 March

Bell Direct
March 22, 2024

Morning Bell 22 March

Bell Direct
March 22, 2024

Morning Bell 21 March

Bell Direct
March 21, 2024

Morning Bell 20 March

Bell Direct
March 20, 2024

Morning Bell 19 March

Bell Direct
March 19, 2024

Morning Bell 18 March

Bell Direct
March 18, 2024

Weekly Wrap 15 March

Bell Direct
March 15, 2024

Morning Bell 15 March

Bell Direct
March 15, 2024